Skip to content
10-Q

Quarterly Report

Loxo Oncology, Inc.

0001104659-18-031328

← back to feed
Filed
May 8, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · Apr 30, 2018 30.08M sh
Capex Q1 2018 · Mar 31, 2018 $746K
Capex Q1 2018 · Mar 31, 2017 $101K
Operating Cash Flow Q1 2018 · Mar 31, 2018 $109.77M
Operating Cash Flow Q1 2018 · Mar 31, 2017 −$26.68M
Short Term Investments Q1 2018 · Mar 31, 2018 $606.45M
Short Term Investments Q1 2018 · Dec 31, 2017 $484.18M
Cash And Equivalents Q1 2018 · Mar 31, 2018 $103.78M
Cash And Equivalents Q1 2018 · Dec 31, 2017 $142.03M
Cash And Equivalents Q1 2018 · Mar 31, 2017 $48.5M
Stockholders Equity Q1 2018 · Mar 31, 2018 $384.42M
Stockholders Equity Q1 2018 · Dec 31, 2017 $378.21M
Current Liabilities Q1 2018 · Mar 31, 2018 $204.5M
Current Liabilities Q1 2018 · Dec 31, 2017 $221.57M
Total Liabilities Q1 2018 · Mar 31, 2018 $364.19M
Total Liabilities Q1 2018 · Dec 31, 2017 $405.23M
Current Assets Q1 2018 · Mar 31, 2018 $720.65M
Current Assets Q1 2018 · Dec 31, 2017 $781.81M
Total Assets Q1 2018 · Mar 31, 2018 $748.61M
Total Assets Q1 2018 · Dec 31, 2017 $783.44M
Sga Expense Q1 2018 · Mar 31, 2018 $12.19M
Sga Expense Q1 2018 · Mar 31, 2017 $4.77M
Rd Expense Q1 2018 · Mar 31, 2018 $31.99M
Rd Expense Q1 2018 · Mar 31, 2017 $20.17M
Net Income Q1 2018 · Mar 31, 2018 −$3.56M
Net Income Q1 2018 · Mar 31, 2017 −$24.53M
Operating Income Q1 2018 · Mar 31, 2018 −$5.76M
Operating Income Q1 2018 · Mar 31, 2017 −$24.94M
Revenue Q1 2018 · Mar 31, 2018 $38.43M